From a precision medicine perspective, how should we be integrating and incorporating ctDNA profiling — i.e., liquid biopsies — with tissue-based whole exome NGS, including longitudinal biopsies?

From a precision medicine perspective, how should we be integrating and incorporating ctDNA profiling — i.e., liquid biopsies — with tissue-based whole exome NGS, including longitudinal biopsies?

From a precision medicine perspective, how should we be integrating and incorporating ctDNA profiling — i.e., liquid biopsies — with tissue-based whole exome NGS, including longitudinal biopsies?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Jean-Charles Soria, MD

Jean-Charles Soria, MD

Professor of Medicine and Medical Oncology South-Paris University Cancer Specialist Institut Gustave Roussy (IGR) Paris, France